302 related articles for article (PubMed ID: 15660214)
21. Naturally occurring anti-Escherichia coli protein antibodies in the sera of healthy humans cause analytical interference in a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay for serodiagnosis of severe acute respiratory syndrome.
Yip CW; Hon CC; Zeng F; Chow KY; Chan KH; Peiris JS; Leung FC
Clin Vaccine Immunol; 2007 Jan; 14(1):99-101. PubMed ID: 17108287
[TBL] [Abstract][Full Text] [Related]
22. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
[TBL] [Abstract][Full Text] [Related]
23. A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus.
Schulze K; Staib C; Schätzl HM; Ebensen T; Erfle V; Guzman CA
Vaccine; 2008 Dec; 26(51):6678-84. PubMed ID: 18805454
[TBL] [Abstract][Full Text] [Related]
24. Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody.
Giménez LG; Rojas J; Rojas A; Mendoza J; Camacho AG
Clin Vaccine Immunol; 2009 Feb; 16(2):241-5. PubMed ID: 19038782
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.
Zhao J; Wang W; Wang W; Zhao Z; Zhang Y; Lv P; Ren F; Gao XM
Clin Vaccine Immunol; 2007 Jul; 14(7):839-46. PubMed ID: 17475765
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Kim TW; Lee JH; Hung CF; Peng S; Roden R; Wang MC; Viscidi R; Tsai YC; He L; Chen PJ; Boyd DA; Wu TC
J Virol; 2004 May; 78(9):4638-45. PubMed ID: 15078946
[TBL] [Abstract][Full Text] [Related]
27. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
[TBL] [Abstract][Full Text] [Related]
28. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
[TBL] [Abstract][Full Text] [Related]
29. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.
Mu F; Niu D; Mu J; He B; Han W; Fan B; Huang S; Qiu Y; You B; Chen W
BMC Microbiol; 2008 Nov; 8():207. PubMed ID: 19038059
[TBL] [Abstract][Full Text] [Related]
30. [Antibody response of patients with severe acute respiratory syndrome (SARS) to nucleocapsid antigen of SARS-associated coronavirus].
Che XY; Hao W; Qiu LW; Pan YX; Liao ZY; Xu H; Chen JJ; Hou JL; Woo PC; Lau SK; Kwok YY; Huang Z
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):637-9. PubMed ID: 12865207
[TBL] [Abstract][Full Text] [Related]
31. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
[TBL] [Abstract][Full Text] [Related]
32. Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection.
Yu F; Le MQ; Inoue S; Hasebe F; Parquet Mdel C; Morikawa S; Morita K
Clin Vaccine Immunol; 2007 Feb; 14(2):146-9. PubMed ID: 17202310
[TBL] [Abstract][Full Text] [Related]
33. Potential cross-reactivity of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid (N)-based IgG ELISA assay for plasma samples from HIV-1 positive intravenous drug users (IDUs).
Yasmon A; Ibrahim F; Bela B; Sjahrurachman A
Acta Med Indones; 2012 Jul; 44(3):193-8. PubMed ID: 22983073
[TBL] [Abstract][Full Text] [Related]
34. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
[TBL] [Abstract][Full Text] [Related]
35. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine.
Zhao P; Cao J; Zhao LJ; Qin ZL; Ke JS; Pan W; Ren H; Yu JG; Qi ZT
Virology; 2005 Jan; 331(1):128-35. PubMed ID: 15582659
[TBL] [Abstract][Full Text] [Related]
36. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice.
Xu P; Wang Y; Tao L; Wu X; Wu W
Biotechnol Lett; 2019 Jul; 41(6-7):867-872. PubMed ID: 31119429
[TBL] [Abstract][Full Text] [Related]
37. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I
Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153
[TBL] [Abstract][Full Text] [Related]
38. Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice.
Zakhartchouk AN; Viswanathan S; Mahony JB; Gauldie J; Babiuk LA
J Gen Virol; 2005 Jan; 86(Pt 1):211-215. PubMed ID: 15604448
[TBL] [Abstract][Full Text] [Related]
39. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay.
Sunwoo HH; Palaniyappan A; Ganguly A; Bhatnagar PK; Das D; El-Kadi AO; Suresh MR
J Virol Methods; 2013 Jan; 187(1):72-8. PubMed ID: 22995576
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a recombinant nucleocapsid protein-based assay for anti-SARS-CoV IgG detection.
Chan PK; Liu EY; Leung DT; Cheung JL; Ma CH; Tam FC; Hui M; Tam JS; Lim PL
J Med Virol; 2005 Feb; 75(2):181-4. PubMed ID: 15602743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
